A landmark study by Hyderabad’s L V Prasad Eye Institute (LVPEI), published in the British Journal of Ophthalmology, has ...
About OKYO OKYO Pharma Limited (NASDAQ: OKYO) is a clinical stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain and dry eye disease, with ...
OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with ...
There is a close connection between the eye and the brain. The retina and the optic nerve are important components of the central nervous system (CNS). Moreover, about 50% of our brain is involved in ...
Abstract: Ocular diseases cover a broad spectrum of conditions impacting eye health and functions, potentially resulting in vision impairment or blindness. Common eye diseases include cataracts, ...
Abstract: Upper limb amputation severely affects the quality of life of individuals. Therefore, developing closed-loop upper-limb prostheses would enhance the sensory-motor capabilities of the ...
Andrew G. Lee, MD, revisits a 1997 case in which recognizing paraneoplastic optic neuropathy led to the diagnosis—and life-saving treatment—of small cell lung carcinoma. In celebration of ...